| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5881311 | Journal of Pain and Symptom Management | 2015 | 8 Pages |
Abstract
When used in doses proportional to the basal opioid regimen, FBT showed a clear superiority and was well tolerated when compared with OM during the first 30Â minutes, which is the approximate target for a timely intervention required for a BTcP medication.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Sebastiano MD, Claudio MD, Arturo MD, Federica MD, Andrea MD, Alessandra BS, Giampiero MD,